Suchergebnisse - "Bosanquet Andrew G"

1

Stability of solutions of antineoplastic agents during preparation and storage for in vitor assays

von: Bosanquet, Andrew G.

1985, in: Cancer chemotherapy and pharmacology

Wird geladen...
2

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays

von: Bosanquet, Andrew G.

1986, in: Cancer chemotherapy and pharmacology

Wird geladen...
3

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays

von: Bosanquet, Andrew G.

1989, in: Cancer chemotherapy and pharmacology

Wird geladen...
4

Effect of cell isolation methods and drug concentration on the use of the Differential Staining Cytotoxicity (DiSC) assay with solid tumours

von: Bosanquet, Andrew G.

1989, in: Cytotechnology

Wird geladen...
5

Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma

von: Bosanquet, Andrew G.

1984, in: Cancer chemotherapy and pharmacology

Wird geladen...
6

Chlorambucil: stability of solutions during preparation and storage

von: Bosanquet, Andrew G.

1986, in: Cancer chemotherapy and pharmacology

Wird geladen...
7

Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays

von: Bosanquet, Andrew G.

1988, in: Cancer chemotherapy and pharmacology

Wird geladen...
8

Airborne cytotoxicity in the DiSC assay caused by solutions of treosulfan but not busulphan

von: Bosanquet, Andrew G.

1994, in: Cytotechnology

Wird geladen...
9

Reduced cell viabilityin vitro following exposure to a routine laboratory disinfectant

von: Boullier, Brian A.

1990, in: Cytotechnology

Wird geladen...
10

Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography

von: Bosanquet, Andrew G.

1985, in: Investigational new drugs

Wird geladen...
11

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

von: Dörken Bernd

2005, in: BMC Cancer

Wird geladen...
12

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

von: Sturm, Isrid

2005, in: BMC cancer

Wird geladen...
13

High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities

von: Thornton, Patrick D.

2003, in: Annals of hematology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!